— Know what they know.
Not Investment Advice

ANIP NASDAQ

ANI Pharmaceuticals, Inc.
1W: +4.0% 1M: +3.3% 3M: +6.4% YTD: +5.5% 1Y: +36.5% 3Y: +86.9% 5Y: +136.1%
$82.72
-0.05 (-0.06%)
 
Weekly Expected Move ±4.2%
$71 $75 $78 $81 $85
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · Alpha Radar Neutral · Power 62 · $1.9B mcap · 19M float · 1.89% daily turnover · Short 59% of daily vol

📊 Key Metrics

TTM
$924M
Revenue
+37.0% YoY
$90M
Net Income
+526.0% YoY
$166M
Free Cash Flow
+236.9% YoY
51.8%
Gross Margin
16.3%
Op. Margin
12.4%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE18.5%
ROA6.6%
ROIC16.9%

Valuation

P/E19.3
P/B3.1
EV/EBITDA7.2

Leverage

Debt/Equity0.60
Current Ratio2.71
Interest Cov.4.6x

Quality Scores

Piotroski F6/9
Altman Z2.46
Beneish M-2.53

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms